Healing the mental health crisis: The emerging potential of psychedelics

With 1 in 4 people experiencing mental health issues worldwide, we ask this incredible panel of health and tech luminaries, can we solve the mental health crisis with psychedelics?

Catherine Bird – Clinical Trials Manager – Psychedelic Trials Group, King’s College London
Christian Angermayer – Co-founder & Chairman – Apeiron Investment Group
Dr Ekaterina Malievskaia – Chief Innovations Office – COMPASS Pathways
Michael Stothard – Principal – firstminute capital

CogX Platform
A new curated social media platform for professionals.
Making sure you’re as prepared as possible for the week ahead.
To find out how CogX can help you radically improve your organisation’s productivity, email info@cogx.live today.

CogX Festival 2023: Register Your Interest Today

YouTube Source for this AI Video

AI video(s) you might be interested in …